{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:53:29Z","timestamp":1771847609397,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ncl.2020.03.008","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T07:50:54Z","timestamp":1591861854000},"page":"711-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immune-Mediated Neuropathies"],"prefix":"10.1016","volume":"38","author":[{"given":"Kelly G.","family":"Gwathmey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Gordon","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ncl.2020.03.008_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neucli.2004.09.005","article-title":"F-waves: neurophysiology and clinical value","volume":"34","author":"Mesrati","year":"2004","journal-title":"Neurophysiol Clin"},{"issue":"21","key":"10.1016\/j.ncl.2020.03.008_bib2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.008_bib3","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"issue":"10045","key":"10.1016\/j.ncl.2020.03.008_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12879-018-2959-2","article-title":"Guillain-Barre syndrome caused by hepatitis E infection: case report and literature review","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.ncl.2020.03.008_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/WCO.0000000000000471","article-title":"Guillain-Barr\u00e9 syndrome and Zika virus outbreaks","volume":"30","author":"Nascimento","year":"2017","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2020.03.008_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.ncl.2020.03.008_bib8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","article-title":"The Guillain-Barr\u00e9 syndrome","volume":"326","author":"Ropper","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2020.03.008_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jns.12104","article-title":"Cytoalbuminologic dissociation in Asian patients with Guillain-Barr\u00e9 and Miller Fisher syndromes","volume":"20","author":"Wong","year":"2015","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1148\/radiology.208.1.9646804","article-title":"Guillain-Barr\u00e9 syndrome: MR imaging findings of the spine in eight patients","volume":"208","author":"Byun","year":"1998","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.008_bib12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.clinph.2015.06.032","article-title":"Ultrasound and electrophysiologic findings in patients with Guillain-Barr\u00e9 syndrome at disease onset and over a period of six months","volume":"127","author":"Grimm","year":"2016","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.008_bib13","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ncl.2020.03.008_bib14","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CND.0000000000000119","article-title":"Human immunoglobulin versus plasmapheresis in Guillain-Barre syndrome and myasthenia gravis: a meta-analysis","volume":"18","author":"Ortiz-Salas","year":"2016","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"8","key":"10.1016\/j.ncl.2020.03.008_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2020.03.008_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.56.8.1104","article-title":"Clinical features and prognosis of Miller Fisher syndrome","volume":"56","author":"Mori","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2020.03.008_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mus.20835","article-title":"Clinical and immunological spectrum of the Miller Fisher syndrome","volume":"36","author":"Lo","year":"2007","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp-2012-302833","article-title":"The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features","volume":"84","author":"Koike","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clinph.2016.11.009","article-title":"Electrophysiology in Fisher syndrome","volume":"128","author":"Kuwabara","year":"2017","journal-title":"Clin Neurophysiol"},{"issue":"3\u20134","key":"10.1016\/j.ncl.2020.03.008_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000494291","article-title":"Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis","volume":"52","author":"Broers","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"13","key":"10.1016\/j.ncl.2020.03.008_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"K\u00f6ller","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.03.008_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2015.11.048","article-title":"Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies","volume":"360","author":"Lozeron","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/acn3.502","article-title":"MRI biomarkers of proximal nerve injury in CIDP","volume":"5","author":"Lichtenstein","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mus.24088","article-title":"Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy","volume":"50","author":"Breiner","year":"2014","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.ncl.2020.03.008_bib26","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/archneur.60.12.1755","article-title":"Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy","volume":"60","author":"Magda","year":"2003","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.008_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-1331.2006.01278.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher","volume":"13","author":"Hughes","year":"2006","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"van Schaik","year":"2018","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2020.03.008_bib29","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mahdi-Rogers","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.008_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000134676.05850.C0","article-title":"Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy","volume":"63","author":"Gorson","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.008_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/mus.25271","article-title":"Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy","volume":"55","author":"Kaplan","year":"2017","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.008_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1468-1331.2009.02802.x","article-title":"A\u00a0nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"17","author":"Cocito","year":"2010","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2020.03.008_bib33","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.ncl.2020.03.008_bib34","article-title":"Multifocal motor neuropathy: controversies and priorities","author":"Yeh","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2020.03.008_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/WCO.0000000000000605","article-title":"Multifocal motor neuropathy","volume":"31","author":"Beadon","year":"2018","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.008_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000282734","article-title":"Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options","volume":"63","author":"Meuth","year":"2010","journal-title":"Eur Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2020.03.008_bib37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/mus.25409","article-title":"Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: a meta-analysis","volume":"55","author":"Racosta","year":"2017","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ncl.2020.03.008_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1468-1331.2009.02568.x","article-title":"Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial","volume":"16","author":"Harbo","year":"2009","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2020.03.008_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1474-4422(19)30144-9","article-title":"Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bunschoten","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2020.03.008_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1085-9489.2006.00060.x","article-title":"Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases","volume":"11","author":"Vital","year":"2006","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.008_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1529-8027.2010.00281.x","article-title":"Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary","volume":"15","author":"Collins","year":"2010","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.008_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.008_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ncl.2020.03.008_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneurol.2017.42","article-title":"The nonsystemic vasculitic neuropathies","volume":"13","author":"Collins","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.008_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ncl.2019.01.013","article-title":"Peripheral nerve vasculitis: classification and disease associations","volume":"37","author":"Gwathmey","year":"2019","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mus.24943","article-title":"Sensory neuronopathies","volume":"53","author":"Gwathmey","year":"2016","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.ncl.2020.03.008_bib48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/jnnp-2014-309730","article-title":"Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy","volume":"86","author":"Antoine","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"Pt 7","key":"10.1016\/j.ncl.2020.03.008_bib49","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awp136","article-title":"The pattern and diagnostic criteria of sensory neuronopathy: a case-control study","volume":"132","author":"Camdessanch\u00e9","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib50","doi-asserted-by":"crossref","first-page":"19-e3","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur J Neurol"},{"issue":"Pt 11","key":"10.1016\/j.ncl.2020.03.008_bib51","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/brain\/124.11.2223","article-title":"The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders","volume":"124","author":"Rees","year":"2001","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.008_bib52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ncl.2018.04.015","article-title":"Paraneoplastic neurologic syndromes","volume":"36","author":"Rosenfeld","year":"2018","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.008_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00234-012-1085-x","article-title":"Sensory neuronopathy involves the spinal cord and brachial plexus: a quantitative study employing multiple-echo data image combination (MEDIC) and turbo inversion recovery magnitude (TIRM)","volume":"55","author":"Bao","year":"2013","journal-title":"Neuroradiology"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:17:24Z","timestamp":1760005044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0733861920300293"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.03.008","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-Mediated Neuropathies","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}